Post-Treatment Neutrophil and Lymphocyte Counts Predict Progression-Free Survival Following First-Line Chemotherapy in Hodgkin’s Lymphoma

Hodgkin’s lymphoma carries an excellent prognosis with modern chemotherapy, but a significant proportion of patients remain refractory to or relapse after first-line treatment. Immunological changes post-treatment, such as chemotherapy-induced neutropenia (CIN) or lymphopenia, have shown prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Grace Fangmin, Goh, Siting, Chang, Esther Wei Yin, Tan, Ya Hwee, Chiang, Jianbang, Yang, Valerie Shiwen, Poon, Eileen Yi Ling, Somasundaram, Nagavalli, Bin Harunal Rashid, Mohamad Farid, Tao, Miriam, Lim, Soon Thye, Ong, Choon Kiat, Chan, Jason Yongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944084/
https://www.ncbi.nlm.nih.gov/pubmed/36810555
http://dx.doi.org/10.3390/hematolrep15010012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944084/
https://www.ncbi.nlm.nih.gov/pubmed/36810555
http://dx.doi.org/10.3390/hematolrep15010012

Ejemplares similares